When clients need help with premarket clearance and approval of new medical devices, Blake Wilson leverages his background in the life sciences industry to smooth regulatory hurdles.

Blake has advised on 510(k) premarket notifications, de novo submissions, premarket approval applications (PMAs), and investigational device exemption applications, among other regulatory filings. He also has experience in drafting clinical trial agreements and contracts for device development, manufacturing, and associated Quality System Regulation (QSR) responsibilities.

Prior to joining Hogan Lovells, Blake worked as an associate at another international law firm and was a lead research assistant at Brown University, where he managed phase 1 and 2 pharmaceutical clinical trials. Blake takes advantage of his clinical research background to help companies navigate the FDA's clinical data requirements.

While attending law school, Blake was executive editor for the University of Pennsylvania Journal of International Law and published a student comment regarding the use and regulation of foreign clinical trials in the FDA's drug marketing approval process. He also served as a judicial intern to the Honorable Leonard P. Stark of the U.S. District Court for the District of Delaware.